Translational-Medicine_Barcelona

[Translational-Medicine_Barcelona @MasterTMedicine]

Join us for the Kick-Off Meeting of the Translational Cancer Research Program at Auditori Esteve @idibaps,📅 on October 31st at 11 AM.
@hospitalclinic @UniBarcelona

📌 Check out the agenda

[Translational-Medicine_Barcelona @MasterTMedicine]

‼️The Translational cancer research program has been created at @idibaps.

The program, coordinated by Prof. Llovet and @cfillat, will promote collaboration among groups to move translational cancer research forward.🔬

@castells_toni @susana_puig @scastellvibel @jcampspolo

[Translational-Medicine_Barcelona @MasterTMedicine]

📢✨ Exciting Job Opportunity!

@JHEP_Reports is seeking an Administrative assistant to Prof. Llovet, the Editor-in-Chief, in Barcelona. @idibaps

Check out the detailed job description here: https://t.co/cMiFoP0oHx

[Translational-Medicine_Barcelona @MasterTMedicine]

‼️The Translational cancer research program has been created at @idibaps.

The program, coordinated by Prof. Llovet and @cfillat, will promote collaboration among groups to move translational cancer research forward.🔬

@castells_toni @susana_puig @scastellvibel @jcampspolo

[IDIBAPS @idibaps]

IDIBAPS creates three multidisciplinary research programs to encourage collaboration among its groups. They are:

-Translational cancer research
-Synaptic autoimmunity in neurology, psychiatry and cognitive neuroscience
-Lymphoid neoplasms

👉https://t.co/9ctejASJqv

[Translational-Medicine_Barcelona @MasterTMedicine]

Congratulations to Prof. Josep M. Llovet on being appointed editor-in-chief of the Journal of Hepatology Reports! @JHEP_Reports

https://t.co/kFWT0xc22p via @hospitalclinic @idibaps

[Translational-Medicine_Barcelona @MasterTMedicine]

Outstanding participation at the Postgraduate Course "From NAFLD to liver cancer" organized by Dr. Josep M. Llovet @IDIBAPS, Dr. Elisabetta Bugatti, and Dr. Philip N. Newsome with ~2500 attendees! @EASLedu @EASLnews #EASLCongress

[HUNTER: Hepatocellular Carcinoma Expediter Network @HCC_HUNTER]

Josep M Llovet kicking off the Post graduate course at EASL ILC in Vienna. A great programme!

[Ramon Bataller @rabataller]

Most patients with IRON overload that I've seen didn't have hemochromatosis. Rather, it was due to excessive alcohol intake.

Why does ALCOHOL induce such strong iron accumulation ?

This excellent review explains it all: https://t.co/gdNNtHXZJl

#livertwitter @medtwitter

[Virginia @VirginiaHdezGea]

Hepatologists, pediatricians, patient associations, an outstanding multidisciplinary session at the Paris PVT meeting! ⁦@ERN_RARE_LIVER⁩ ⁦@EASLnews⁩ ⁦@ValdigGroup⁩ ⁦@AEEHLiver⁩

[Asociación Contra el Cáncer BURGOS 💚 @ContraCancerBU]

El Dr. Mikel Eguiguren, oncólogo radioterápico del Hospital Universitario de Txagorritxu, en Vitoria, da respuesta a las preguntas planteadas por pacientes con esta enfermedad. La Asociación Española Contra el Cáncer está las 24 horas del día a tu lado en el 900 100 036.

[Asociación Española Contra el Cáncer @ContraCancerEs]

La Asociación Española Contra el cáncer se une a la campaña #PrevCan, es hora de actuar en prevención del cáncer para reducir la incidencia en Europa.
➡️Se tratará cada recomendació del Código Europeo Contra el Cáncer, como no fumar. #CancerCode @cancernurseEU @esmo.org

[Ramon Bataller @rabataller]

Planning the #TLM22 in Barcelona’s airport.

Looking forward to learning a lot and have some fun with my liver colleagues.

@AASLDtweets #LiverTwitter

[IDIBAPS @idibaps]

Un fàrmac experimental mostra signes d’activitat antitumoral i bon perfil de seguretat en pacients amb càncer hepàtic sense alternatives de tractament

Els resultats de l'assaig clínic de fase I/II es van presentar a l'#ENASymp22

👉 https://t.co/v38Czpq7Fn

[Translational-Medicine_Barcelona @MasterTMedicine]

Your month @AMesropi @JAbrilFo :)

[Mount Sinai Tisch Cancer Center @TischCancer]

New approvals for liver cancer mark ‘golden age’ of treatment https://t.co/zbZxuRIqsq
The breakthrough clinicians needed came in 2007, when Josep M. Llovet, MD, @IcahnMountSinai, presented results of the SHARP trial at the ASCO Annual Meeting.

[Milan @MKDmilanM]

#ILC2021 wrap up session part 2
👉Liver tumours-Josep M. Llovet
👉Metabolic-Massimo Pinzani
@EASLedu @EASLnews @EuropeLiver @Marko_Korenjak
@hepar_centar @VeronikaVsetic
@BeaCredi

[EASL Education @EASLedu]

Josep M. Llovet wrapping up the #liver #tumors topic, you can download the corresponding Best of #ILC2021 slide deck:👉https://t.co/STBDXymT6D

[AACR @AACR]

Submit an abstract by Feb 16 for the AACR conference on Advances in the Pathogenesis and Molecular Therapies of Liver Cancer (May 5-8, Boston), chaired by Richard S. Finn @dgsomucla, Josep M. Llovet @IcahnMountSinai, and Jessica @Zucmanrossi.
https://t.co/vCtqhendQk
#AACRliver22

[AACR @AACR]

Register by March 24 to get the lowest rates for the AACR conference on Advances in the Pathogenesis and Molecular Therapies of Liver Cancer (May 5-8, Boston), chaired by Richard S. Finn, Josep M. Llovet, and Jessica Zucman-Rossi.
https://t.co/jSaMTrgnmJ
#AACRliver22

[Translational-Medicine_Barcelona @MasterTMedicine]

This is just a small representation of the fantastic women of the Translational Research Group in Hepatic Oncology. We are grateful for the opportunity to work with all of them, three students of @MasterTMedicine #WomenInScience @AMesropi @LauraTorrensF @CMontironi @CarmenAO92

[Translational-Medicine_Barcelona @MasterTMedicine]

Please feel free to share the link with anyone you know who may be interested! #HiringPostdoc Functional cancer genomics, great infrastructure and a very liveable city #Barcelona #postdocinbarcelona #researchinbarcelona #workinbarcelona #sciencebarcelona https://t.co/Tn8qZ5dIno

[Hospital Clínic @hospitalclinic]

📅 Avui és el #DiaMundialCàncer

El #càncer és una malaltia freqüent degut a l'envelliment de la població i la detecció precoç. La prevenció, un enfocament transversal i la recerca són elements clau.

➕ Info a #PortalClínic 👉 https://t.co/aPlRBSuDoD

@fundacionBBVA